SAN DIEGO, Oct. 26 /PRNewswire/ — Neurocrine Biosciences, Inc.
NBIX) announced today that Kevin Gorman, President and Chief
Executive Officer of Neurocrine Biosciences, will be presenting at
the Oppenheimer 21st Annual Healthcare Conference in New York.
The live presentation takes place on Tuesday, November 2, 2010
at 11:25 a.m. Eastern Time / 8:25 a.m. Pacific Time. The
presentation will be webcast and may be accessed on the Company’s
website at http://www.neurocrine.com.
If you are unable to attend the webcast and would like further
information on this announcement please contact Investor Relations
at Neurocrine Biosciences at (858) 617-7600. Viewers are
encouraged to visit the website approximately 5 minutes prior to
the presentation to download or install any necessary software.
A replay of the presentation will be available approximately
one hour after the conclusion of the live event and will be
archived on the website for two weeks.
Neurocrine Biosciences, Inc. is a biopharmaceutical company
focused on neurological and endocrine diseases and disorders. Our
product candidates address some of the largest pharmaceutical
markets in the world including endometriosis, anxiety, depression,
pain, diabetes, irritable bowel syndrome, insomnia and other
neurological and endocrine related diseases and disorders.
Neurocrine Biosciences, Inc. news releases are available through
the Company’s website via the internet at http://www.neurocrine.com.